CNE000000P61
CNE000000P61
SHANDONG LUKANG PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.766.115.537 | 6.233.090.168 | 7.5% |
| Cost of Revenue | 4.493.270.341 | 4.739.468.857 | 5.2% |
| Gross Profit | 1.272.845.196 | 1.493.621.312 | 14.8% |
| 998.127.762 | 1.069.062.586 | 6.6% | |
| Operating Income | 274.717.434 | 424.558.726 | 35.3% |
| Pretax Income | 161.207.120 | 433.901.413 | 62.8% |
| Net Income Common Stockholders | 112.304.824 | 394.615.736 | 71.5% |
| -- | -- | -- | |
| -- | -- | -- |